Clinical Trials Logo

Pseudohypoparathyroidism clinical trials

View clinical trials related to Pseudohypoparathyroidism.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03761290 Terminated - Clinical trials for Albright Hereditary Osteodystrophy

Glucose Homeostasis in Pseudohypoparathyroidism

Start date: June 19, 2019
Phase:
Study type: Observational

It is increasingly recognized that Pseudohypoparathyroidism type 1A (PHP1A) is associated with an increased risk of type 2 diabetes but the mechanism is unknown. In this pilot study we will assess β-cell function in patients with PHP1A and pseudopseudohypoparathyroidism PPHP.

NCT ID: NCT01398774 Terminated - Clinical trials for Albright Hereditary Osteodystrophy

Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a

Start date: June 2011
Phase:
Study type: Observational

The investigators would like to learn more about the metabolic consequences of pseudohypoparathyroidism type 1a in children, adolescents and adults with this condition. People with pseudohypoparathyroidism 1a are at risk for development of obesity. To better understand the cause of overweight or obesity, investigators are measuring body composition and resting energy expenditure (REE), which is the amount of calories burned while completely at rest. The investigators also want to determine the amount of body fat.